These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24114764)

  • 1. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
    Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT; Gemenetzidis E; Patel D; Tariq R; Nadir A; Bahta AW; Waseem A; Hutchison IL
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
    Umair A; Tarakji B; Ibrahim A; Nasser A; Fq A; Shreen A
    Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A; Ali M; Odell EW; Fortune F; Teh MT
    Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas.
    Ma H; Dai H; Duan X; Tang Z; Liu R; Sun K; Zhou K; Chen H; Xiang H; Wang J; Gao Q; Zou Y; Wan H; Teh MT
    Oncotarget; 2016 Aug; 7(34):54555-54563. PubMed ID: 27409343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT
    PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis.
    Teh MT; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Purdie K; Harwood C; Wan H; Odell EW; Hackshaw A; Waseem A
    Int J Cancer; 2013 May; 132(9):2095-106. PubMed ID: 23034676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropeptide genes
    Clin Epigenetics; ; . PubMed ID: 29682090
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.